Table of Content
1. Executive Summary
2. Global Meningococcal Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Meningococcal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Meningococcal Vaccine Market by Type
3.3.1: Polysaccharide
3.3.2: Conjugate Vaccines
3.3.3: Combination Vaccines
3.3.4: Men B Vaccines
3.3.5: Others
3.4: Global Meningococcal Vaccine Market by End Use
3.4.1: Retail Pharmacies
3.4.2: Hospital Pharmacies
3.4.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Meningococcal Vaccine Market by Region
4.2: North American Meningococcal Vaccine Market
4.2.2: North American Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
4.3: European Meningococcal Vaccine Market
4.3.1: European Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
4.3.2: European Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
4.4: APAC Meningococcal Vaccine Market
4.4.1: APAC Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
4.4.2: APAC Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
4.5: ROW Meningococcal Vaccine Market
4.5.1: ROW Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
4.5.2: ROW Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Meningococcal Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Meningococcal Vaccine Market by End Use
6.1.3: Growth Opportunities for the Global Meningococcal Vaccine Market by Region
6.2: Emerging Trends in the Global Meningococcal Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Meningococcal Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Meningococcal Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Merck
7.2: Baxter International
7.3: JN International Medical
7.4: Biomed
7.5: Pfizer
7.6: Glaxosmithkline
7.7: Serum Institute India